Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC)

Peer Review reports

Original Submission
9 Jul 2023	Submitted	Original manuscript
28 Jul 2023	Author responded	Author comments - Susana Fiorentino
Resubmission - Version 2
28 Jul 2023	Submitted	Manuscript version 2
18 Aug 2023	Author responded	Author comments - Susana Fiorentino
Resubmission - Version 3
18 Aug 2023	Submitted	Manuscript version 3
Publishing
24 Aug 2023	Editorially accepted
5 Sep 2023	Article published	10.1186/s12906-023-04139-w

Back to article page